Skip to main content
Equibles
LCTX logo

LCTX · Lineage Cell Therapeutics, Inc. · Congressional Trades

Track LCTX — free

Use LCTX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LCTX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.00 +0.02 (+1.52%) At close · Oct 23
Russell 2000 member Rebalance outlook locked
Customer concentration — top 2 customers 92% of revenue

2 customers — 92% of revenue (the year ended December 31, 2025)

“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”

One customer — 92% of revenue (the year ended December 31, 2024)

“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
View the 10-K filed Mar 5, 2026
Market Cap
$252.91M
Shares
252.91M
Volume · Oct 23 1.15M Avg daily vol (3M) 1.25M

Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.

Query congressional trades through the STOCK Act API or MCP →

No Congressional Trades

No congressional trading data is available for this listed security yet.

Key facts CIK 876343 CUSIP 53566P109 13F (30d) 26 filings 26 filers Visit website Investor relations